Acute administration of typical and atypical antipsychotics reduces EEG gamma power, but only the preclinical compound LY379268 reduces the ketamine-induced rise in gamma power

International Journal of Neuropsychopharmacology

Volumn 15, Issue 5, 2012, Pages 657-668

  Jones, Nigel C ^a   Reddy, Maya ^a   Anderson, Paul ^a   Salzberg, Michael R ^a   O'Brien, Terence J ^a   Pinault, Didier ^b  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b UNIVERSITÉ DE STRASBOURG   (France)

Author keywords

Antipsychotic; EEG; gamma power; ketamine; schizophrenia

Indexed keywords

4 AMINO 2 OXABICYCLO[3.1.0]HEXANE 4,6 DICARBOXYLIC ACID; CLOZAPINE; HALOPERIDOL; KETAMINE;

ANIMAL EXPERIMENT; ARTICLE; BRAIN FUNCTION; CONTROLLED STUDY; ELECTRODE; ELECTROENCEPHALOGRAM; HYPERACTIVITY; LOCOMOTION; MALE; NONHUMAN; OSCILLATION; PRIORITY JOURNAL; RAT; SKULL;

AMINO ACIDS; ANIMALS; ANTIPSYCHOTIC AGENTS; BICYCLO COMPOUNDS, HETEROCYCLIC; BRAIN WAVES; CEREBRAL CORTEX; CLOZAPINE; DRUG ADMINISTRATION SCHEDULE; ELECTRODES, IMPLANTED; EXCITATORY AMINO ACID ANTAGONISTS; HALOPERIDOL; KETAMINE; MALE; RATS; RATS, WISTAR; RECEPTORS, N-METHYL-D-ASPARTATE;

EID: 84861057747     PISSN: 14611457     EISSN: 14695111     Source Type: Journal    
DOI: 10.1017/S1461145711000848     Document Type: Article

References (54)

1. Awad H, Hubert GW, Smith Y, Levey AI, et al. (2000). Activation of metabotropic glutamate receptor 5 has direct excitatory effects and potentiates NMDA receptor currents in neurons of the subthalamic nucleus. Journal of Neuroscience 20, 7871-7879.
2. Baldessarini RJ, Centorrino F, Flood JG, Volpicelli SA, et al. (1993). Tissue concentrations of clozapine and its metabolites in the rat. Neuropsychopharmacology 9, 117-124. (Pubitemid 23275837)
3. Baldeweg T, Spence S, Hirsch SR, Gruzelier J (1998). Gamma-band electroencephalographic oscillations in a patient with somatic hallucinations. Lancet 352, 620-621. (Pubitemid 28380147)
4. Bartos M, Vida I, Jonas P (2007). Synaptic mechanisms of synchronized gamma oscillations in inhibitory interneuron networks. Nature Reviews Neuroscience 8, 45-56. (Pubitemid 46011998)
5. Buzsaki G, Draguhn A (2004). Neuronal oscillations in cortical networks. Science 304, 1926-1929.
6. Campbell A, Herschel M, Cohen BM, Baldessarini RJ (1980). Tissue levels of haloperidol by radioreceptor assay and behavioral effects of haloperidol in the rat. Life Sciences 27, 633-640. (Pubitemid 11235867)
7. Cartmell J, Monn JA, Schoepp DD (2000). Attenuation of specific PCP-evoked behaviors by the potent mGlu2/3 receptor agonist, LY379268 and comparison with the atypical antipsychotic, clozapine. Psychopharmacology (Berlin) 148, 423-429. (Pubitemid 30169761)
8. Ehrlichman RS, Gandal MJ, Maxwell CR, Lazarewicz MT, et al. (2009). N-methyl-d-aspartic acid receptor antagonist-induced frequency oscillations in mice recreate pattern of electrophysiological deficits in schizophrenia. Neuroscience 158, 705-712.
9. Engel AK, Fries P, Singer W (2001). Dynamic predictions : oscillations and synchrony in top-down processing. Nature Reviews Neuroscience 2, 704-716. (Pubitemid 33674816)
10. Fisahn A, Pike FG, Buhl EH, Paulsen O (1998). Cholinergic induction of network oscillations at 40 Hz in the hippocampus in vitro. Nature 394, 186-189. (Pubitemid 28325972)
11. Flynn G, Alexander D, Harris A, Whitford T, et al. (2008). Increased absolute magnitude of gamma synchrony in first-episode psychosis. Schizophrenia Research 105, 262-271.
12. Ford JM, Roach BJ, Faustman WO, Mathalon DH (2008). Out-of-synch and out-of-sorts : dysfunction of motorsensory communication in schizophrenia. Biological Psychiatry 63, 736-743. (Pubitemid 351400763)
13. Fuchs EC, Zivkovic AR, Cunningham MO, Middleton S, et al. (2007). Recruitment of parvalbumin-positive interneurons determines hippocampal function and associated behavior. Neuron 53, 591-604. (Pubitemid 46216760)
14. Gordon E, Williams LM, Haig AR, Bahramali H, et al. (2001). Symptom profile and 'gamma' processing in schizophrenia. Cognitive Neuropsychiatry 6, 2001.
15. Gross J, Schnitzler A, Timmermann L, Ploner M (2007). Gamma oscillations in human primary somatosensory cortex reflect pain perception. PLoS Biology 5, e133.
16. Hakami T, Jones NC, Tolmacheva MA, Gaudias J, et al. (2009). NMDA Receptor Hypofunction Induces Generalized and Persistent Aberrant Gamma Oscillations Independent of Hyperlocomotion and Conscious Sensorimotor Processing. PLoS One 4, e6755.
17. Herrmann CS, Demiralp T (2005). Human EEG gamma oscillations in neuropsychiatric disorders. Clinical Neurophysiology 116, 2719-2733. (Pubitemid 41714021)
18. Homayoun H, Jackson ME, Moghaddam B (2005). Activation of metabotropic glutamate 2/3 receptors reverses the effects of NMDA receptor hypofunction on prefrontal cortex unit activity in awake rats. Journal of Neurophysiology 93, 1989-2001. (Pubitemid 40404399)
19. Homayoun H, Moghaddam B (2008). Orbitofrontal cortex neurons as a common target for classic and glutamatergic antipsychotic drugs. Proceedings of the National Academy of Sciences USA 105, 18041-18046.
20. Hong LE, Summerfelt A, Buchanan RW, O'Donnell P, et al. (2010). Gamma and delta neural oscillations and association with clinical symptoms under subanesthetic ketamine. Neuropsychopharmacology 35, 632-640.
21. Hong LE, Summerfelt A, McMahon R, Adami H, et al. (2004). Evoked gamma band synchronization and the liability for schizophrenia. Schizophrenia Research 70, 293-302. (Pubitemid 39141107)
22. Howard MW, Rizzuto DS, Caplan JB, Madsen JR, et al. (2003). Gamma oscillations correlate with working memory load in humans. Cerebral Cortex 13, 1369-1374. (Pubitemid 37466784)
23. Imre G (2007). The preclinical properties of a novel group II metabotropic glutamate receptor agonist LY379268. CNS Drug Reviews 13, 444-464. (Pubitemid 350233471)
24. Imre G, Fokkema DS, Den Boer JA, Ter Horst GJ (2006a). Dose-response characteristics of ketamine effect on locomotion, cognitive function and central neuronal activity. Brain Research Bulletin 69, 338-345.
25. Imre G, Fokkema DS, Ter Horst GJ (2006b). Subchronic administration of LY354740 does not modify ketamine-evoked behavior and neuronal activity in rats. European Journal of Pharmacology 544, 77-81. (Pubitemid 44164452)
26. Jackson ME, Homayoun H, Moghaddam B (2004). NMDA receptor hypofunction produces concomitant firing rate potentiation and burst activity reduction in the prefrontal cortex. Proceedings of the National Academy of Sciences USA 101, 8467-8472. (Pubitemid 38736598)
27. Joliot M, Ribary U, Llinas R (1994). Human oscillatory brain activity near 40 Hz coexists with cognitive temporal binding. Proceedings of the National Academy of Sciences USA 91, 11748-11751. (Pubitemid 24356422)
28. Jones NC, Martin S, Megatia I, Hakami T, et al. (2010). A genetic epilepsy rat model displays endophenotypes of psychosis. Neurobiology of Disease 39, 116-125.
29. Krystal JH, Karper LP, Seibyl JP, Freeman GK, et al. (1994). Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses. Archives of General Psychiatry 51, 199-214. (Pubitemid 24081509)
30. Kwon JS, O'Donnell BF, Wallenstein GV, Greene RW, et al. (1999). Gamma frequency-range abnormalities to auditory stimulation in schizophrenia. Archives of General Psychiatry 56, 1001-1005. (Pubitemid 29526383)
31. Lahti AC, Koffel B, LaPorte D, Tamminga CA (1995). Subanesthetic doses of ketamine stimulate psychosis in schizophrenia. Neuropsychopharmacology 13, 9-19.
32. Lazarewicz MT, Ehrlichman RS, Maxwell CR, Gandal RJ, et al. (2010). Ketamine modulates theta and gamma oscillations. Journal of Cognitive Neuroscience 22, 1452-1464.
33. Lecourtier L, Homayoun H, Tamagnan G, Moghaddam B (2007). Positive allosteric modulation of metabotropic glutamate 5 (mGlu5) receptors reverses N-methyl-D-aspartate antagonist-induced alteration of neuronal firing in prefrontal cortex. Biological Psychiatry 62, 739-746. (Pubitemid 47374648)
34. Lee KH, Williams LM, Breakspear M, Gordon E (2003a). Synchronous gamma activity : a review and contribution to an integrative neuroscience model of schizophrenia. Brain Research. Brain Research Reviews 41, 57-78. (Pubitemid 36044594)
35. Lee KH, Williams LM, Haig A, Gordon E (2003b). 'Gamma (40 Hz) phase synchronicity' and symptom dimensions in schizophrenia. Cognitive Neuropsychiatry 8, 57-71. (Pubitemid 36168373)
36. Lisman JE, Coyle JT, Green RW, Javitt DC, et al. (2008). Circuit-based framework for understanding neurotransmitter and risk gene interactions in schizophrenia. Trends in Neuroscience 31, 234-242.
37. Ma J, Leung LS (2007). The supramammillo-septalhippocampal pathway mediates sensorimotor gating impairment and hyperlocomotion induced by MK-801 and ketamine in rats. Psychopharmacology (Berlin) 191, 961-974. (Pubitemid 46399137)
38. Malhotra AK, Pinals DA, Adler CM, Elman I, et al. (1997). Ketamine-induced exacerbation of psychotic symptoms and cognitive impairment in neuroleptic-free schizophrenics. Neuropsychopharmacology 17, 141-150. (Pubitemid 27365955)
39. Miyamoto S, Duncan GE, Marx CE, Lieberman JA (2005). Treatments for schizophrenia : a critical review of pharmacology and mechanisms of action of antipsychotic drugs. Molecular Psychiatry 10, 79-104. (Pubitemid 40139590)
40. Moghaddam B, Adams B, Verma A, Daly D (1997). Activation of glutamatergic neurotransmission by ketamine: a novel step in the pathway from NMDA receptor blockade to dopaminergic and cognitive disruptions associated with the prefrontal cortex. Journal of Neuroscience 17, 2921-2927. (Pubitemid 27155025)
41. Moghaddam B, Adams BW (1998). Reversal of phencyclidine effects by a group II metabotropic glutamate receptor agonist in rats. Science 281, 1349-1352. (Pubitemid 28406826)
42. Monn JA, Valli MJ, Massey SM, Hansen MM, et al. (1999). Synthesis, pharmacological characterization, and molecular modeling of heterobicyclic amino acids related to (+)-2-aminobicyclo[3. 1. 0] hexane-2, 6-dicarboxylic acid (LY354740): identification of two new potent, selective, and systemically active agonists for group II metabotropic glutamate receptors. Journal of Medicinal Chemistry 42, 1027-1040. (Pubitemid 29153432)
43. Paxinos G, Watson C (2005). The Rat Brain in Stereotactic Coordinates. San Diego: Elsevier, Academic Press.
44. Pinault D (2008). N-methyl d-aspartate receptor antagonists ketamine and MK-801 induce wake-related aberrant gamma oscillations in the rat neocortex. Biological Psychiatry 63, 730-735. (Pubitemid 351400766)
45. Schwieler L, Linderholm KR, Nilsson-Todd LK, Erhardt S, et al. (2008). Clozapine interacts with the glycine site of the NMDA receptor : electrophysiological studies of dopamine neurons in the rat ventral tegmental area. Life Sciences 83, 170-175.
46. Seeman P, Guan HC (2009). Glutamate agonists for treating schizophrenia have affinity for dopamine D2High and D3 receptors. Synapse 63, 705-709.
47. Spencer KM, Nestor PG, Niznikiewicz MA, Salisbury DF, et al. (2003). Abnormal neural synchrony in schizophrenia. Journal of Neuroscience 23, 7407-7411. (Pubitemid 36999532)
48. Spencer KM, Niznikiewicz MA, Nestor PG, Shenton ME, et al. (2009). Left auditory cortex gamma synchronization and auditory hallucination symptoms in schizophrenia. BMC Neuroscience 10, 85.
49. Spencer KM, Niznikiewicz MA, Shenton ME, McCarley RW (2008a). Sensory-evoked gamma oscillations in chronic schizophrenia. Biological Psychiatry 63, 744-747.
50. Spencer KM, Salisbury DF, Shenton ME, McCarley RW (2008b). Gamma-band auditory steady-state responses are impaired in first episode psychosis. Biological Psychiatry 64, 369-375.
51. Tallon-Baudry C, Bertrand O, Peronnet F, Pernier J (1998). Induced gamma-band activity during the delay of a visual short-term memory task in humans. Journal of Neuroscience 18, 4244-4254. (Pubitemid 28243818)
52. Turetsky BI, Siegel SJ (2007). Persistent auditory-evoked gamma band oscillations in schizophrenia. Conference Proceedings. American College of Neuropsychopharmacology. Boca Raton, FL, USA.
53. Uhlhaas PJ, Singer W (2010). Abnormal neural oscillations and synchrony in schizophrenia. Nature Reviews Neuroscience 11, 100-113.
54. Van Den Buuse M, Garner B, Gogos A, Kusljic S (2005). Importance of animal models in schizophrenia research. Australian and New Zealand Journal of Psychiatry 39, 550-557. (Pubitemid 41602539)